303 related articles for article (PubMed ID: 2788830)
1. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
Arenson MS
Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic actions of oxotremorine on murine skeletal muscle. Evidence against muscarinic modulation of acetylcholine release.
Hong SJ; Chang CC
Brain Res; 1990 Nov; 534(1-2):142-8. PubMed ID: 2073579
[TBL] [Abstract][Full Text] [Related]
3. [Effect of cholinergic compounds on spontaneous quantal mediator release at the neuromuscular synapse of the frog].
Bukharaeva EA; Nikol'skiĭ EE; Giniatullin RA
Neirofiziologiia; 1986; 18(5):586-93. PubMed ID: 2877404
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic regulation of the evoked quantal release at frog neuromuscular junction.
Nikolsky EE; Vyskocil F; Bukharaeva EA; Samigullin D; Magazanik LG
J Physiol; 2004 Oct; 560(Pt 1):77-88. PubMed ID: 15254150
[TBL] [Abstract][Full Text] [Related]
5. Activation of protein kinase C increases acetylcholine release from frog motor nerves by a direct action on L-type Ca(2+) channels and apparently not by depolarisation of the terminal.
Arenson MS; Evans SC
Neuroscience; 2001; 104(4):1157-64. PubMed ID: 11457598
[TBL] [Abstract][Full Text] [Related]
6. [Muscarinic agonists do not alter the process of spontaneous quantum secretion of the mediator from motor nerve endings in the frog].
Nikol'skiĭ EE; Bukharaeva EA
Biull Eksp Biol Med; 1987 Feb; 103(2):183-5. PubMed ID: 2880613
[TBL] [Abstract][Full Text] [Related]
7. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
Molgó J; del Pozo E; Baños JE; Angaut-Petit D
Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
[TBL] [Abstract][Full Text] [Related]
8. The effects of muscarine and atropine reveal that inhibitory autoreceptors are present on frog motor nerve terminals but are not activated during transmission.
Arenson MS
Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):128-33. PubMed ID: 1648671
[TBL] [Abstract][Full Text] [Related]
9. Phenthonium, a quaternary derivative of (-)-hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals.
Fann ML; Souccar C; Lapa AJ
Br J Pharmacol; 1990 Jul; 100(3):441-6. PubMed ID: 2390670
[TBL] [Abstract][Full Text] [Related]
10. Depression of miniature endplate potential frequency by acetylcholine and its analogues in frog.
Nikolsky EE; Bukharaeva EA; Strunsky EG; Vyskocil F
Br J Pharmacol; 1991 Dec; 104(4):1024-32. PubMed ID: 1667283
[TBL] [Abstract][Full Text] [Related]
11. Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin.
Kim YI; Lømo T; Lupa MT; Thesleff S
J Physiol; 1984 Nov; 356():587-99. PubMed ID: 6520797
[TBL] [Abstract][Full Text] [Related]
12. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
Montoya GA; Molgó J; Lemeignan M; Lechat P
Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
[TBL] [Abstract][Full Text] [Related]
13. Mg++ antagonism of a prejunctional opiate receptor mediated effect at the frog neuromuscular junction.
Durham HD; Frank GB
Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):72-82. PubMed ID: 6295295
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic M1 acetylcholine receptors regulate the non-quantal release of acetylcholine in the rat neuromuscular junction via NO-dependent mechanism.
Malomouzh AI; Mukhtarov MR; Nikolsky EE; Vyskočil F
J Neurochem; 2007 Sep; 102(6):2110-2117. PubMed ID: 17561934
[TBL] [Abstract][Full Text] [Related]
15. Chlorpromazine, but not chlorpromazine sulphoxide, stimulates transmitter release from motor nerve terminals.
Sahaf ZY; Publicover SJ
Brain Res; 1987 Dec; 437(2):397-401. PubMed ID: 2893656
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction.
Duncan CJ; Publicover SJ
J Physiol; 1979 Sep; 294():91-103. PubMed ID: 229216
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
Arenson MS; Gill DS
Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
[TBL] [Abstract][Full Text] [Related]
18. [Effect of tubocurarine on the quantum release of acetylcholine during the infrequent stimulation of a motor nerve].
Grigor'ev VM; Danilov AF; Skliarov AI
Fiziol Zh SSSR Im I M Sechenova; 1988 Oct; 74(10):1377-82. PubMed ID: 3265920
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.
Tian L; Prior C; Dempster J; Marshall IG
J Physiol; 1994 May; 476(3):517-29. PubMed ID: 7914535
[TBL] [Abstract][Full Text] [Related]
20. Postsynaptic effects of methoctramine at the mouse neuromuscular junction.
Re L; Cola V; Fulgenzi G; Marinelli F; Concettoni C; Rossini L
Neuroscience; 1993 Nov; 57(2):451-7. PubMed ID: 8115049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
